Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This newly described syndrome is characterized by osteosclerosis, developmental delay and craniosynostosis.
Features include very common findings: Brachycephaly, Macrocephaly, Hypertelorism, and Broad forehead and others; and common findings: Craniosynostosis. 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 3 | Macrocephaly, Craniosynostosis, Facial palsy |
Biomarker and diagnostic research for osteosclerosis-developmental delay-craniosynostosis syndrome has been reported in the published literature.
Phenotype severity distribution: 8 very common features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for osteosclerosis-developmental delay-craniosynostosis syndrome.
204 publications have been identified in PubMed for osteosclerosis-developmental delay-craniosynostosis syndrome. Research spans Review / Meta-Analysis (58%), Basic Science / Preclinical (13%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 119 | 58% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Visual impairment, Damage to the optic nerve (optic atrophy) |
Brain and nerves | 2 | Headache, Mild global developmental delay |
Ears | 1 | Hearing loss (hearing impairment) |
Muscles | 1 | Damage to the optic nerve (optic atrophy) |
Bones and joints | 1 | Increased bone density (increased bone mineral density) |
Laboratory research |
26 |
13% |
Patient case studies | 22 | 11% |
Disease patterns and progression | 18 | 9% |
Other research | 13 | 6% |
Testing and diagnosis research | 5 | 2% |
Clinical study results | 1 | 0% |
Fujiwara K (2026). [PMID: 41418585](https://pubmed.ncbi.nlm.nih.gov/41418585/). *Auris Nasus Larynx*. [Case Report / Case Series]
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Beuriat PA (2026). [PMID: 42115454](https://pubmed.ncbi.nlm.nih.gov/42115454/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Morin G (2026). [PMID: 41173190](https://pubmed.ncbi.nlm.nih.gov/41173190/). *Kidney Int*. [Review / Meta-Analysis]
Toljan K (2026). [PMID: 42066585](https://pubmed.ncbi.nlm.nih.gov/42066585/). *J Neurol Sci*. [Basic Science / Preclinical]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]